We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has given its blessing to Wellstat Therapeutics’ Vistogard for the emergency treatment of adults and children who receive an overdose of chemotherapy treatment fluorouracil or capecitabine. Read More
The FDA has granted approval to Genentech’s Alecensa for metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer in patients whose disease has worsened after taking Pfizer’s Xalkori, or who could not tolerate the treatment. Read More
The treatment is for patients with refractory diffuse large B cell lymphoma, primary mediastinal B cell lymphoma and transformed follicular lymphoma. Read More
Indian regulators have approved a generic version of Gilead’s hepatitis C drug Harvoni (ledipasvir-sofosbuvir) in a country with the highest infection rate on the planet. Read More
The FDA has granted orphan drug and rare pediatric disease designations to ARMGO Pharma’s ARM210 for the treatment of Duchenne Muscular Dystrophy. Read More
The FDA has blessed a new treatment for the bleeding disorder von Willebrand disease. The FDA disclosed Tuesday that it has approved California drugmaker Baxalta’s Vonvendi (recombinant von Willebrand factor) for on-demand treatment of adult patients with the inherited disorder. Read More
The FDA approved Alexion Pharmaceuticals’enzyme replacement drug Kanuma for an ultra rare disorder known as lysosomal acid lipase deficiency in pediatric and adult patients. Read More